Browse the complete record of transactions filed by 장순호, Director. Director active across 1 company, notably 화일약품. In total, 17,943 disclosures have been recorded. History available since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Jang Soon-ho is a Board Member at Hwa-il Pharmaceutical, where he contributes to the governance and strategic direction of the company. His role involves providing counsel and overseeing the company's activities to ensure compliance and efficiency. Jang Soon-ho is valued for his expertise and vision in the sector.